Nancy King to Therapeutic Human Experimentation
This is a "connection" page, showing publications Nancy King has written about Therapeutic Human Experimentation.
Connection Strength
0.163
-
King NM, Henderson G. Treatments of last resort: informed consent and the diffusion of new technology. Mercer Law Rev. 1991; 42(3):1007-50.
Score: 0.099
-
Macklin R, Shepherd L, Dreger A, Asch A, Baylis F, Brody H, Churchill LR, Coleman CH, Cowan E, Dolgin J, Downie J, Dresser R, Elliott C, Epright MC, Feder EK, Glantz LH, Grodin MA, Hoffman W, Hoffmaster B, Hunter D, Iltis AS, Kahn JD, King NM, Kraft R, Kukla R, Leavitt L, Lederer SE, Lemmens T, Lindemann H, Marshall MF, Merz JF, Miller FH, Mohrmann ME, Morreim H, Nass M, Nelson JL, Noble JH, Reis E, Reverby SM, Silvers A, Sousa AC, Spece RG, Strong C, Swazey JP, Turner L. The OHRP and SUPPORT--another view. N Engl J Med. 2013 Jul 11; 369(2):e3.
Score: 0.029
-
Kipnis K, King NM, Nelson RM. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver. IRB. 2006 Mar-Apr; 28(2):16-9.
Score: 0.018
-
Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK. Therapeutic misconception in early phase gene transfer trials. Soc Sci Med. 2006 Jan; 62(1):239-53.
Score: 0.017